Summarized by Masters of Longevity from Longevity Technology.
Tiny Health’s funding and research plans are the focus of a business-and-science article that previews its microbiome research, AI development, and clinical ambitions.
Key Takeaways
- The company raised $33 million in a Series B round led by B Capital, bringing total funding to $46 million.
- It launched a $5 million Microbiome Research Program to accelerate translational microbiome work.
- The firm reports an AI trained on nearly 200,000 microbiome profiles and plans expanded clinical and interventional studies.
